journal article·2019-12-18Open access

In Vivo Optical Performance of a New Class of Near-Infrared-Emitting Conjugated Polymers: Borylated PF8-BT

Paul Robert Neumann, Daniel L. Crossley, Michael Turner, Michael Ingleson, Mark Green, Jianghong Rao, Lea Ann Dailey

ACS Applied Materials & Interfaces· Volume 11· Issue 50

Abstract

Borylated poly(fluorene-benzothiadiazoles) (PF8-BT) are π-conjugated polymers (CPs) with deep-red/ near-infrared (NIR) absorption and emission profiles suitable for in vivo optical imaging. A fully borylated PF8-BT derivative (P4) was encapsulated in pegylated poly(lactic- co -glycolic acid) (PEG–PLGA) nanoparticles and compared with a reference NIR-emitting CP (PCPDTBT) or indocyanine green (ICG). All formulations satisfied quality requirements for parenterally administered diagnostics. P4 nanoparticles had higher quantum yield (2.3%) than PCPCDTBT (0.01%) or ICG nanoparticles (1.1%). The signal/background ratios (SBRs) of CP systems P4 and PCPDTBT in a phantom mouse (λ em = 820 nm) increased linearly with fluorophore mass (12.5–100 μg/mL), while the SBRs of ICG decreased above 25 μg/mL. P4 nanoparticles experienced <10% photobleaching over 10 irradiations (PCPDTBT: ∼25% and ICG: >44%). In a mouse tumor xenograft model, P4 nanoparticles showed a 5-fold higher SBR than PCPDTBT particles with fluorophore accumulation in the liver > spleen > tumor. Blood chemistry and tissue histology showed no abnormalities compared to untreated animals after a single administration.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Luminescence and Fluorescent Materials · Conducting polymers and applications · Organic Light-Emitting Diodes Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutical Technology and Biopharmaceutics, Martin-Luther-University Halle-Wittenberg, Halle/Saale 06120, Germany

Department of Chemical Sciences, University of Huddersfield, Huddersfield HD1 3DH, U.K.

School of Chemistry, University of Manchester, Manchester M13 9PL, U.K.

School of Chemistry, University of Edinburgh, Edinburgh EH9 3FJ, U.K.

Department of Physics, King’s College London, London WC2R 2LS, U.K.

Department of Radiology and Chemistry, Stanford University, Stanford, California 94305, United States

Funding

Engineering and Physical Sciences Research Council · Cambridge Display Technology Limited

References (59)

Show source-provided references
1. 10.1021/acsami.7b0847310.1021/acsami.7b08473 ↗
2. 10.1002/anie.20130342010.1002/anie.201303420 ↗
3. 10.1002/adma.20120124510.1002/adma.201201245 ↗
4. 10.1021/ac103140x10.1021/ac103140x ↗
5. 10.1021/ja107196s10.1021/ja107196s ↗
6. 10.1021/ja100217910.1021/ja1002179 ↗
7. 10.1039/c0pp00106f10.1039/c0pp00106f ↗
8. 10.1039/C0JM02935A10.1039/C0JM02935A ↗
9. 10.1021/ja202945g10.1021/ja202945g ↗
10. 10.1021/ja512304510.1021/ja5123045 ↗
11. 10.1039/C5TC00847F10.1039/C5TC00847F ↗
12. 10.1016/j.cbpa.2003.08.00710.1016/j.cbpa.2003.08.007 ↗
13. 10.1039/C5EE01974E10.1039/C5EE01974E ↗
14. 10.1038/nnano.2013.30210.1038/nnano.2013.302 ↗
15. 10.1039/C6SC01251E10.1039/C6SC01251E ↗
16. 10.1021/acsnano.6b0594910.1021/acsnano.6b05949 ↗
17. 10.1039/C5TB01827G10.1039/C5TB01827G ↗
18. 10.1021/acsnano.6b0016810.1021/acsnano.6b00168 ↗
19. 10.1016/j.matpr.2017.04.11410.1016/j.matpr.2017.04.114 ↗
20. 10.1002/smll.20120025810.1002/smll.201200258 ↗
21. 10.1039/C6RA25004A10.1039/C6RA25004A ↗
22. 10.1016/j.jconrel.2014.03.02610.1016/j.jconrel.2014.03.026 ↗
23. 10.1007/s40005-012-0024-510.1007/s40005-012-0024-5 ↗
24. 10.1039/c2cs15344k10.1039/c2cs15344k ↗
25. 10.1002/jin2.5210.1002/jin2.52 ↗
26. 10.1039/C6NR09162H10.1039/C6NR09162H ↗
27. Assay Cascade Protocols|Nanotechnology Characterization Lab (NCL). https://ncl.cancer.gov/resources/assay-cascade-protocols (accessed May 28, 2019).
28. 10.1038/nmeth.252110.1038/nmeth.2521 ↗
29. 10.1073/pnas.171891711510.1073/pnas.1718917115 ↗
30. 10.1208/s12248-016-9969-z10.1208/s12248-016-9969-z ↗
31. 10.1002/jps.2115210.1002/jps.21152 ↗
32. Tetrahydrofuran Toxicity Effects. Eur. Comm. ESIS; IUCLID Dataset, 2010, (109-99-9) (Tetrahydrofuran), 170.
33. University College London Hospitals Foundation NHS Trust. Pharmacy Department · 2010
34. 10.1039/C4NR01491J10.1039/C4NR01491J ↗
35. 10.1039/C4CS00487F10.1039/C4CS00487F ↗
36. 10.1039/C6PP00160B10.1039/C6PP00160B ↗
37. 10.1021/am502733n10.1021/am502733n ↗
38. 10.1021/nn800590n10.1021/nn800590n ↗
39. 10.1039/c0nr00746c10.1039/c0nr00746c ↗
40. 10.1152/jappl.1976.40.4.57510.1152/jappl.1976.40.4.575 ↗
41. 10.1016/1010-6030(95)04292-X10.1016/1010-6030(95)04292-X ↗
42. 10.1002/adma.20140090610.1002/adma.201400906 ↗
43. 10.1002/adma.20150228510.1002/adma.201502285 ↗
44. 10.1088/0953-8984/22/33/33421710.1088/0953-8984/22/33/334217 ↗
45. 10.1562/0031-8655(2000)0720392HCDACA2.0.CO210.1562/0031-8655(2000)0720392HCDACA2.0.CO2 ↗
46. 10.1089/pho.2006.24.51410.1089/pho.2006.24.514 ↗
47. 10.1038/s41598-018-25383-y10.1038/s41598-018-25383-y ↗
48. 10.1007/s10549-011-1419-010.1007/s10549-011-1419-0 ↗
49. 10.2174/092986705350732410.2174/0929867053507324 ↗
50. 10.1016/j.jconrel.2012.02.01210.1016/j.jconrel.2012.02.012 ↗
51. 10.1039/C4CS00294F10.1039/C4CS00294F ↗
52. 10.1021/acs.chemrev.6b0007310.1021/acs.chemrev.6b00073 ↗
53. 10.1039/C4TB01822B10.1039/C4TB01822B ↗
54. 10.1007/s11051-012-1316-410.1007/s11051-012-1316-4 ↗
55. 10.1002/wnan.141810.1002/wnan.1418 ↗
56. 10.1002/wnan.14310.1002/wnan.143 ↗
57. 10.1016/j.addr.2018.07.00710.1016/j.addr.2018.07.007 ↗
58. 10.1007/s11307-018-1255-210.1007/s11307-018-1255-2 ↗
59. 10.1038/s41467-017-00545-010.1038/s41467-017-00545-0 ↗